MedPath
NMPA Approval

Ceftriaxone Sodium for Injection

国药准字H44021532

September 14, 2024

Drug Information

注射用头孢曲松钠

注射剂

0.5g(按C18H18N8O7S3计)

化学药品

September 14, 2024

Company Information

Applicant Company

广州市白云区同和街云祥路88号

Manufacturing Company

广州市白云区同和街云祥路88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用头孢曲松钠 - NMPA 批准文号 | MedPath